These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 12982020)
1. [Trefocitone therapy of dystrophy in infants]. ROTTINI G Lattante; 1952 Jun; 23(6):347-52. PubMed ID: 12982020 [No Abstract] [Full Text] [Related]
2. [Use of royal jelly in dystrophy in young infants]. QUADRI S Clin Pediatr (Bologna); 1956 Sep; 38(9):686-90. PubMed ID: 13404748 [No Abstract] [Full Text] [Related]
3. [Dystrophy in suckling infants]. SOYSAL SS Tip Fak Mecm; 1952; 15(2):763-73. PubMed ID: 13049350 [No Abstract] [Full Text] [Related]
4. [Changes in the blood lipids in dystrophy in infants]. de BARROS J; TAVARES AH Port Med; 1960 Jun; 44():396-403. PubMed ID: 13797110 [No Abstract] [Full Text] [Related]
5. [On the use of 4-chloro-19-nortesterone acetate in dystrophy of infants]. IAFUSCO F; BUFFA V Pediatria (Napoli); 1960 Jun; 68():447-54. PubMed ID: 14405757 [No Abstract] [Full Text] [Related]
6. [Social aspects of dystrophy of nutritional origin in infants in Madras, India]. ACHAR S Med Hyg (Geneve); 1950 Aug; 8(175 bis):291. PubMed ID: 15438267 [No Abstract] [Full Text] [Related]
7. [Chronic digestive and nutritional disorders of infants; decomposition and dystrophy]. MONTANARO O; PAGLILLA CJ; SARACO EG Sem Med; 1952 Jul; 101(3):89-90. PubMed ID: 12995052 [No Abstract] [Full Text] [Related]
11. [Treatment of severe infant dystrophy with methandrostenolone]. BELLORA A; ACEVEDO A; JOSE A; SUAREZ BH Sem Med; 1961 Dec; 119():2137-43. PubMed ID: 13866932 [No Abstract] [Full Text] [Related]
12. [Modern concepts and new trends in therapy of dystrophy]. SCROGGIE A; WIEDERHOLD A Arch Pediatr Urug; 1955 May; 26(5):561-3; concl. PubMed ID: 13239446 [No Abstract] [Full Text] [Related]
13. [Blood catalase activity in normal and dystrophic infants]. ANGELINI B; FANTUZZI B; GRASSO E Minerva Nipiol; 1952; 2(4):97-9. PubMed ID: 13025090 [No Abstract] [Full Text] [Related]
14. [Medico-social factors in infant dystrophy in Sullana]. VELASQUEZ GIL G Rev Med Peru; 1951 Apr; 22(268):339-60. PubMed ID: 14865230 [No Abstract] [Full Text] [Related]
15. [Antireticular cytotoxic serum in premature and dystrophic infants]. BROGI G; VERROTTI M Atti Accad Fisiocrit Siena Med Fis; 1951; 19(1):26-7. PubMed ID: 14858241 [No Abstract] [Full Text] [Related]
16. [Contribution to the physiopathological treatment of dystrophy; experimental and clinical study]. MONGRUT MUNOZ O An Fac Med Lima; 1950; 33(2):141-244. PubMed ID: 14819656 [No Abstract] [Full Text] [Related]
17. [Disorders of carbohydrates metabolism in infant dystrophy]. SALAZAR DE SOUSA C Acta Pediatr Esp; 1951 Nov; 9(107):1315-72. PubMed ID: 14894240 [No Abstract] [Full Text] [Related]
18. [Use of fat emulsions in the treatment of severe dystrophy in infancy]. TORRES-MARTY L Acta Pediatr Esp; 1956 Jun; 14(162):508-13. PubMed ID: 13339373 [No Abstract] [Full Text] [Related]
19. [Considerations on infant dystrophy]. de ALMEIDA Rev Port Pediatr Pueric; 1961 Feb; 24():55-61. PubMed ID: 24545379 [No Abstract] [Full Text] [Related]